Optimizing 131I-mIBG Dosimetry: Validation of Simplified Time-Point and Segmentation Approaches

Abstract Purpose To evaluate simplified dosimetry methods for 131 I-mIBG therapy that maintain agreement with reference method while reducing clinical workflow burdens, particularly beneficial for pediatric applications. Methods In 24 patients, we implemented a hybrid protocol combining planar whole-body scans (1, 24, 48 h p.i.) with 24 h SPECT/CT for whole-body and liver dosimetry. Three liver segmentation methods were compared on SPECT/CT: whole-organ manual delineation (reference), 4 mL homogeneous sphere, and 4 mL peak sphere. To estimate time-integrated activity coefficients (TIACs) we modeled biokinetics with monoexponential using: full three-time-point data (reference), reduced combinations (1–2, 1–3, 2–3), Hänscheid single-time-point method, and population-based half-lives. Statistical analysis included linear mixed-effects modeling for segmentation comparisons and Bland-Altman analysis for TIAC method validation. Results The median absorbed dose was 0.36 mGy/MBq for liver and 0.09 mGy/MBq for whole-body. Among simplified protocols, dual-time-point 24–48 h imaging demonstrated the least bias, with liver absorbed doses showing − 0.02 mGy/MBq (limits of agreement: -0.08 to 0.04 mGy/MBq) and whole-body absorbed doses 0.001 mGy/MBq (limits of agreement: -0.004 to 0.005 mGy/MBq) compared to the full three-time-point reference results. Among single-time-point methods, for both liver and whole-body, the Hänscheid approach applied at 48 h demonstrated superior performance. The 4 mL peak sphere overestimated absorbed doses by 69% versus whole-organ delineation (0.61 vs. 0.36 mGy/MBq, p < 0.001), and homogeneous spheres underestimated by 8% (0.33 vs. 0.36 mGy/MBq, p = 0.046). Conclusions Clinically feasible 131 I-mIBG dosimetry can be achieved through: (1) dual 24 h/48 h imaging (< 6% mean bias), (2) single 48 h Hänscheid method (< 6% mean bias), and (3) homogeneous sphere liver segmentation ( < 8% mean difference from reference).

Authors

Institutions

Publication Details

Journal
Nuclear Medicine and Molecular Imaging
Published
2025-11-25
DOI
https://doi.org/10.1007/s13139-025-00959-5
Primary Topic
Advanced Radiotherapy Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimizing 131I-mIBG Dosimetry: Validation of Simplified Time-Point and Segmentation Approaches

Sara Kurkowska, Hanna Piwowarska-Bilska, Bożena Birkenfeld, Carlos Uribe et al.
Nuclear Medicine and Molecular Imaging
Advanced Radiotherapy Techniques
article

Optimizing 131I-mIBG Dosimetry: Validation of Simplified Time-Point and Segmentation Approaches

Sara Kurkowska, Hanna Piwowarska-Bilska, Bożena Birkenfeld, Carlos Uribe, Małgorzata Poniatowska
article en

Abstract

Abstract Purpose To evaluate simplified dosimetry methods for 131 I-mIBG therapy that maintain agreement with reference method while reducing clinical workflow burdens, particularly beneficial for pediatric applications. Methods In 24 patients, we implemented a hybrid protocol combining planar whole-body scans (1, 24, 48 h p.i.) with 24 h SPECT/CT for whole-body and liver dosimetry. Three liver segmentation methods were compared on SPECT/CT: whole-organ manual delineation (reference), 4 mL homogeneous sphere, and 4 mL peak sphere. To estimate time-integrated activity coefficients (TIACs) we modeled biokinetics with monoexponential using: full three-time-point data (reference), reduced combinations (1–2, 1–3, 2–3), Hänscheid single-time-point method, and population-based half-lives. Statistical analysis included linear mixed-effects modeling for segmentation comparisons and Bland-Altman analysis for TIAC method validation. Results The median absorbed dose was 0.36 mGy/MBq for liver and 0.09 mGy/MBq for whole-body. Among simplified protocols, dual-time-point 24–48 h imaging demonstrated the least bias, with liver absorbed doses showing − 0.02 mGy/MBq (limits of agreement: -0.08 to 0.04 mGy/MBq) and whole-body absorbed doses 0.001 mGy/MBq (limits of agreement: -0.004 to 0.005 mGy/MBq) compared to the full three-time-point reference results. Among single-time-point methods, for both liver and whole-body, the Hänscheid approach applied at 48 h demonstrated superior performance. The 4 mL peak sphere overestimated absorbed doses by 69% versus whole-organ delineation (0.61 vs. 0.36 mGy/MBq, p < 0.001), and homogeneous spheres underestimated by 8% (0.33 vs. 0.36 mGy/MBq, p = 0.046). Conclusions Clinically feasible 131 I-mIBG dosimetry can be achieved through: (1) dual 24 h/48 h imaging (< 6% mean bias), (2) single 48 h Hänscheid method (< 6% mean bias), and (3) homogeneous sphere liver segmentation ( < 8% mean difference from reference).

Nuclear Medicine and Molecular Imaging
BC Cancer Agency (CA), Spinal Cord Injury BC (CA), Pomeranian Medical University (PL)
Openalex Percentile: Top 54%
Advanced Radiotherapy Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.